Repression of cell transformation with human pea3
CA 2332634 A1 · Owner: Xing, Xiangming · Inventors: Xing, Xiangming; Hung, Mien-Chie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to the fields of cancer therapy and gene therapy. More particularly, it demonstrates that PEA3 as exemplified by , mPEA3, and hPEA3, is a tumor suppressor and may be used to treat various forms of cancer, for example neu- or ras--mediated cancers.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 15, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 15, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 15, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.